Articles from Pediatrix Medical Group, Inc.

Pediatrix Medical Group, Inc. (NYSEMD), a leading provider of physician services, today reported earnings of $0.36 per share for the three months ended December 31, 2024. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.51.
By Pediatrix Medical Group, Inc. · Via Business Wire · February 20, 2025

Pediatrix® Medical Group, Inc. (NYSEMD), a leading provider of physician services, is pleased to announce NEO: The Conference for Neonatology, a premier educational event dedicated to advancing the field of neonatology. The conference will be held Feb. 19-21 in Las Vegas, Nevada, and will bring together neonatologists, pediatricians, advanced practitioners and allied health professionals from around the globe.
By Pediatrix Medical Group, Inc. · Via Business Wire · February 11, 2025

Pediatrix Medical Group, Inc. (NYSEMD) will host an investor conference call and webcast on Thursday, February 20, 2025 at 9:00 a.m. ET to discuss results from operations for the quarter ended December 31, 2024. A detailed press release will be issued the morning of February 20, 2025 before the securities markets open.
By Pediatrix Medical Group, Inc. · Via Business Wire · February 10, 2025

Pediatrix Medical Group, Inc. (NYSEMD) (“Pediatrix” or “the Company”), a leading provider of physician services, today announced a leadership transition to accelerate its progress in executing a transformational strategy designed to create value for shareholders and other stakeholders. To best position Pediatrix to implement the strategy, which is based on recommitting to the highest standards in clinical excellence and strengthening the Company’s hospital relationships, the Company’s Board of Directors has appointed Executive Chair Mark S. Ordan to return to his former position as Chief Executive Officer, effective immediately. James D. Swift, M.D., a veteran Pediatrix executive who assumed the CEO role in January 2023, will assist Mr. Ordan during the transition period.
By Pediatrix Medical Group, Inc. · Via Business Wire · January 13, 2025

Pediatrix Medical Group, Inc. (NYSEMD), a leading provider of physician services, today reported earnings of $0.23 per share for the three months ended September 30, 2024. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.44.
By Pediatrix Medical Group, Inc. · Via Business Wire · November 1, 2024

Pediatrix Medical Group, Inc. (NYSEMD) will host an investor conference call and webcast on Friday, November 1, 2024 at 9:00 a.m. ET to discuss results from operations for the quarter ended September 30, 2024. A detailed press release will be issued the morning of November 1, 2024 before the securities markets open.
By Pediatrix Medical Group, Inc. · Via Business Wire · October 16, 2024

Pediatrix Medical Group, Inc. (NYSEMD), a leading provider of physician services, today reported a loss of $1.84 per share for the three months ended June 30, 2024. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.34.
By Pediatrix Medical Group, Inc. · Via Business Wire · August 6, 2024

Pediatrix Medical Group, Inc. (NYSEMD) will host an investor conference call and webcast on Tuesday, August 6, 2024 at 9:00 a.m. ET to discuss results from operations for the quarter ended June 30, 2024. A detailed press release will be issued the morning of August 6, 2024 before the securities markets open.
By Pediatrix Medical Group, Inc. · Via Business Wire · July 18, 2024

Pediatrix Medical Group, Inc. (NYSEMD) is scheduled to present at the following healthcare conferences:
By Pediatrix Medical Group, Inc. · Via Business Wire · May 22, 2024

Pediatrix Medical Group, Inc. (NYSEMD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings of $0.05 per share for the three months ended March 31, 2024. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.20.
By Pediatrix Medical Group, Inc. · Via Business Wire · May 7, 2024

Pediatrix Medical Group, Inc. (NYSEMD) will host an investor conference call and webcast on Tuesday, May 7, 2024 at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2024. A detailed press release will be issued the morning of May 7, 2024 before the securities markets open.
By Pediatrix Medical Group, Inc. · Via Business Wire · April 22, 2024

Pediatrix Medical Group, Inc. (NYSEMD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported a loss from continuing operations of $1.50 per share for the three months ended December 31, 2023. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.32.
By Pediatrix Medical Group, Inc. · Via Business Wire · February 20, 2024

Pediatrix Medical Group, Inc. (NYSEMD), the nation’s leading provider of highly specialized health care for women, children and babies, will host the top meetings in neonatal-perinatal medicine Feb. 19-24 in Las Vegas, Nevada. Specialty Review in Neonatology and NEO: The Conference for Neonatology will take place concurrently, each addressing many of the most critical and controversial issues that influence the clinical practice of neonatal-perinatal medicine today. The meetings will host more than 600 combined attendees comprising neonatologists, neonatology fellows, pediatricians, advanced practice nurses and other allied health professionals, in addition to exhibitors and sponsors.
By Pediatrix Medical Group, Inc. · Via Business Wire · February 13, 2024

Pediatrix Medical Group, Inc. (NYSEMD) will host an investor conference call and webcast on Tuesday, February 20, 2024 at 9:00 a.m. ET to discuss results from operations for the quarter ended December 31, 2023. A detailed press release will be issued the morning of February 20, 2024 before the securities markets open.
By Pediatrix Medical Group, Inc. · Via Business Wire · February 7, 2024

Pediatrix Medical Group, Inc. (NYSEMD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.26 per share for the three months ended September 30, 2023. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.32.
By Pediatrix Medical Group, Inc. · Via Business Wire · November 2, 2023

Pediatrix Medical Group, Inc. (NYSEMD) will host an investor conference call and webcast on Thursday, November 2, 2023 at 9:00 a.m. ET to discuss results from operations for the quarter ended September 30, 2023. A detailed press release will be issued the morning of November 2, 2023 before the securities markets open.
By Pediatrix Medical Group, Inc. · Via Business Wire · October 20, 2023

Pediatrix Medical Group, Inc. (NYSEMD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.34 per share for the three months ended June 30, 2023. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.39.
By Pediatrix Medical Group, Inc. · Via Business Wire · August 3, 2023

Pediatrix Medical Group, Inc. (NYSEMD) will host an investor conference call and webcast on Thursday, August 3, 2023 at 9:00 a.m. ET to discuss results from operations for the quarter ended June 30, 2023. A detailed press release will be issued the morning of August 3, 2023 before the securities markets open.
By Pediatrix Medical Group, Inc. · Via Business Wire · July 18, 2023

Pediatrix Medical Group, Inc. (NYSEMD), the nation’s leading provider of highly specialized health care for women, children and babies, today announced that its board of directors has appointed Sylvia Young, a recognized leader in healthcare and long-term healthcare executive, as an independent director, effective May 12, 2023.
By Pediatrix Medical Group, Inc. · Via Business Wire · May 4, 2023

Pediatrix Medical Group, Inc. (NYSEMD) today announced that it will present on Tuesday, May 9, 2023 at 5:00 pm PT to investors attending the 2023 Bank of America Health Care Conference in Las Vegas, Nevada. The presentation will be broadcast through live audio webcast and can be accessed at Pediatrix’s website, www.pediatrix.com/investors.
By Pediatrix Medical Group, Inc. · Via Business Wire · May 3, 2023

Pediatrix Medical Group, Inc. (NYSEMD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.17 per share for the three months ended March 31, 2023. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.23.
By Pediatrix Medical Group, Inc. · Via Business Wire · May 2, 2023

Pediatrix Medical Group, Inc. (NYSEMD) will host an investor conference call and webcast on Tuesday, May 2, 2023 at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2023. A detailed press release will be issued the morning of May 2, 2023 before the securities markets open.
By Pediatrix Medical Group, Inc. · Via Business Wire · April 26, 2023

Pediatrix Medical Group, Inc. (NYSEMD) today announced that its board of directors has elected James D. Swift, M.D., the Company’s chief executive officer, as a director effective March 8, 2023. This appointment fills a seat previously held by Roger J. Medel, M.D.
By Pediatrix Medical Group, Inc. · Via Business Wire · March 8, 2023

Pediatrix Medical Group, Inc. (NYSEMD), the nation’s leading provider of highly specialized health care for women, babies and children, will host the top meeting in neonatal medicine Feb. 22-24 in Las Vegas, Nevada. More than 385 physicians, allied health professionals, advanced practitioners/registered nurses, residents/fellows and exhibitors are expected to attend NEO: The Conference for Neonatology, where experts will address many of the most critical and controversial issues that influence the clinical practice of newborn medicine.
By Pediatrix Medical Group, Inc. · Via Business Wire · February 21, 2023

Pediatrix Medical Group, Inc. (NYSEMD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.29 per share for the three months ended December 31, 2022. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.47.
By Pediatrix Medical Group, Inc. · Via Business Wire · February 17, 2023

Pediatrix Medical Group, Inc. (NYSEMD) will host an investor conference call and webcast on Friday, February 17, 2023 at 9:00 a.m. ET to discuss results from operations for the quarter ended December 31, 2022. A detailed press release will be issued the morning of February 17, 2023 before the securities markets open.
By Pediatrix Medical Group, Inc. · Via Business Wire · February 6, 2023

Pediatrix Medical Group, Inc. (NYSEMD), the nation’s leading provider of highly specialized health care for women, babies and children, today announced that the Company’s board of directors has appointed James D. Swift, M.D., as chief executive officer, to succeed Mark S. Ordan, who has been named executive chair of the Company’s board of directors and has served as chief executive officer since July 2020. Guy P. Sansone, who previously served as chair of the Company’s board of directors since July 2020, has been named lead independent director. Each of these transitions will go into effect at the end of the year.
By Pediatrix Medical Group, Inc. · Via Business Wire · December 15, 2022

Pediatrix® Medical Group, Inc. (NYSEMD), the nation’s leading provider of highly specialized health care for women, babies and children, today released its inaugural sustainability report which outlines Pediatrix’s approach and business practices related to its Environmental, Social and Governance (ESG) efforts. The report is a milestone in the company’s commitment to transparently providing ESG information to its key stakeholders.
By Pediatrix Medical Group, Inc. · Via Business Wire · December 1, 2022

Pediatrix Medical Group, Inc. (NYSEMD) today announced that it will present on Tuesday, November 8, 2022 at 3:15 p.m. PT to investors attending the Credit Suisse 31st Annual Healthcare Conference in Rancho Palos Verdes, California. The presentation will be broadcast through live audio webcasts.
By Pediatrix Medical Group, Inc. · Via Business Wire · November 7, 2022

Pediatrix Medical Group, Inc. (NYSEMD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.35 per share for the three months ended September 30, 2022. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.40.
By Pediatrix Medical Group, Inc. · Via Business Wire · November 3, 2022

Pediatrix Medical Group, Inc. (NYSEMD) will host an investor conference call and webcast on Thursday, November 3, 2022 at 9:00 a.m. ET to discuss results from operations for the quarter ended September 30, 2022. A detailed press release will be issued the morning of November 3, 2022 before the securities markets open.
By Pediatrix Medical Group, Inc. · Via Business Wire · October 21, 2022

Pediatrix Medical Group, Inc. (NYSEMD) today provided commentary on the final rule issued on August 19, 2022 by the Departments of the Treasury, Labor, and Health and Human Services related to the No Surprises Act.
By Pediatrix Medical Group, Inc. · Via Business Wire · August 22, 2022

Pediatrix Medical Group, Inc. (NYSEMD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.36 per share for the three months ended June 30, 2022. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.47.
By Pediatrix Medical Group, Inc. · Via Business Wire · August 4, 2022

Pediatrix Medical Group, Inc. (NYSEMD) will host an investor conference call and webcast on Thursday, August 4, 2022 at 9:00 a.m. ET to discuss results from operations for the quarter ended June 30, 2022. A detailed press release will be issued the morning of August 4, 2022 before the securities markets open.
By Pediatrix Medical Group, Inc. · Via Business Wire · July 13, 2022